BELMA ZACHARIAH: Open Payments
NPI 1568074532 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 37 payments from 17 companies in 2025. Trend: 2023 $1,318 · 2024 $1,115 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $150 |
| Novo Nordisk Inc | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| Dexcom, Inc. | 3 | $65 |
| SANOFI-AVENTIS U.S. LLC | 2 | $55 |
| Seqirus USA Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $28 |
| PFIZER INC. | 1 | $24 |
Products named: JARDIANCE, MOUNJARO, Dexcom G6 Transmitter, TZIELD, Ozempic, Flucelvax, Wegovy, FARXIGA.
Industry payments across TX — which companies pay providers there.
